MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Caffeine"

  • 2026 International Congress

    Impact of Caffeine Consumption on Clinical Phenotype and Non-Motor Symptoms in Parkinson’s Disease

    A. Rekik, M. Abid, R. Guizani, K. Jemai, A. Mili, H. Slimene, A. Hassine, S. Naija, S. Ben Amor (Sousse, Tunisia)

    Objective: To determine the impact of daily caffeine consumption (presence, quantity) on the clinical phenotype of patients with Parkinson’s Disease (PD), focusing on age of…
  • 2026 International Congress

    Occupational Solvent Exposure and Parkinson’s Disease: An Observational Study in PPMI Online

    F. Luna-Rangel, H. Martinez, O. Gutierrez-Treviño, C. Armengol-Garcia, J. Luna, B. Perez Martinez, J. Figueroa-Sanchez (San Pedro, Mexico)

    Objective: To investigate the association between occupational solvent exposure and Parkinson’s disease using data from the PPMI Online cohort. Background: Environmental toxicant exposure has been…
  • 2025 International Congress

    The influence of Caffeine intake on Type 2 Diabetes Mellitus mediated risk of Parkinson’s Disease.

    K. Mallavarapu, E. Tan (Singapore, Singapore)

    Objective: The objectives are to investigate if a diagnosis of Type 2 Diabetes Mellitus (T2DM) is associated with increased risk of developing Parkinson's Disease (PD)…
  • 2025 International Congress

    Gene-Caffeine Interaction in Parkinson’s Disease: A Case-Control Study of Alpha-synuclein SNPs

    BG. Yan, E. Ng, Y. Zhao, EK. Tan (Singapore, Singapore)

    Objective: Investigating the interaction between genetic susceptibility and caffeine intake in modulating Parkinson’s disease (PD) risk. Background: PD arises from a complex interplay of genetic…
  • 2024 International Congress

    Shifting Tides of Caffeine: Evaluating Consumption Patterns In Parkinson’s disease Progression

    S. Bouhadoun, S. Zolfaghari, A. Delva, T. Kouchache, A. Pelletier, R. Postuma (Montréal, Canada)

    Objective: This investigation aims to explore temporal shifts in caffeine consumption throughout the Parkinson’s disease (PD) course. Background: Caffeine has been consistently associated with a…
  • 2024 International Congress

    Understanding the neuroprotective mechanism of ilex Paraguariensis (Yerba mate) in a Drosophila melanogaster alpha-synuclein model of Parkinson’s disease

    A. Tschopp, P. Ballestero, G. Decurgez, H. Hauche, T. Eidelman, M. Bordone, N. Muraro, J. Ferrario (CABA, Argentina)

    Objective: To investigate behavioral and cellular changes in the brain of a Drosophila melanogaster model of Parkinson’s Disease (PD) exposed to yerba mate [YM] extract.…
  • 2024 International Congress

    ilex Paraguariensis (Yerba mate) modulates the AMPK pathway and downstream key metabolic mechanism that may explain its neuroprotective role.

    J. Ferrario, H. Hauche, L. Tschopp, T. Eidelman, M. Bordone (Buenos Aires, Argentina)

    Objective: To investigate the molecular pathways regulated by yerba mate [YM] extract and its main active compounds in a neuronal cell line as a cue…
  • 2023 International Congress

    Association between lifestyle and environmental factors with disease severity and age at onset in multi-ethnic Malaysian Parkinson’s disease patients

    JP. Schee, HC. Ting, ZL. Loo, AMF. Dy Closas, TS. Toh, JW. Hor, YW. Tay, JL. Lim, LC. Lit, AH. Tan, SY. Lim (Kuala Lumpur, Malaysia)

    Objective: We explored the association between self-reported exposure to caffeine, smoking, and environmental toxins (pesticides, chemical solvents, heavy metals, other chemicals, and fumes) with Aao…
  • 2023 International Congress

    Effect of dietary caffeine on brain dopamine transporter binding in Parkinson’s disease

    E. Saarinen, T. Kuusimäki, K. Lindholm, EA. Honkanen, T. Noponen, M. Seppänen, K. Murtomäki, T. Mertsalmi, E. Jaakkola, E. Mäkinen, M. Eklund, S. Nuuttila, R. Levo, KR. Chaudhuri, A. Antonini, J. Joutsa, F. Scheperjans, V. Kaasinen (Turku, Finland)

    Objective: To investigate the relationship between dietary caffeine intake and striatal dopamine function over the progression of Parkinson’s disease (PD). Background: The association between high…
  • 2023 International Congress

    Caffeine Intake Interacts with Gene Variants in Parkinson’s disease

    E. Tan, Y. Ong, X. Deng, H. Li, D. Heng, K. Narasimhalu, L. Chan, P. Kumar, W. Au, P. Ratnagopal, L. Tan (Singapore, Singapore)

    Objective: We investigate interactions of caffeine intake with PD risk variants and determine PD risk estimates in caffeine-drinkers carrying these variants. Background: Caffeine intake reduces…
  • 1
  • 2
  • 3
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley